Chapter 22: Pulmonary Hypertension and Thromboembolic Disease

• Section 22.1: Pulmonary Hypertension

  • 22.1.1: Classification
    • Group 1 (PAH)
    • Groups 2-5
  • 22.1.2: Management
    • Vasodilators (prostacyclins, endothelin receptor antagonists)
    • Calcium channel blockers

• Section 22.2: Pulmonary Embolism and DVT

  • 22.2.1: Risk Factors and Pathophysiology
    • Virchow's triad
    • Thrombus formation and migration
  • 22.2.2: Treatment
    • Anticoagulation (DOACs)
    • Thrombolysis for massive PE